Lamictal and Krill oil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamictal and Krill oil. Common interactions include depression among females and dizziness among males.

The phase IV clinical study analyzes what interactions people who take Lamictal and Krill oil have. It is created by eHealthMe based on reports of 43 people who take Lamictal and Krill oil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

43 people who take Lamictal and Krill oil together, and have interactions are studied.

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 77,484 Lamictal users for its effectiveness, alternative drugs and more.

What is Krill oil?

Krill oil has active ingredients of krill oil. It is often used in high blood cholesterol. eHealthMe is studying from 4,231 Krill oil users for its effectiveness, alternative drugs and more.

Number of Lamictal and Krill oil reports submitted per year:

Common Lamictal and Krill Oil drug interactions by gender *:

female:

Depression
Fatigue
Dizziness
Drug ineffective
Erythema
Infective pulmonary exacerbation of cystic fibrosis
Peripheral swelling
Rash
Rheumatoid arthritis
Urticaria

male:

Dizziness
Aphasia
Vision blurred
Amnesia
Depression
Balance disorder
Cerebral atrophy
Gait disturbance
Memory impairment
Muscular weakness

Common Lamictal and Krill Oil drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Angina pectoris
Blood pressure increased
Heart rate increased
Tic

20-29:

n/a

30-39:

Infective pulmonary exacerbation of cystic fibrosis
Dizziness
Back pain
Nasopharyngitis
Pelvic pain
Productive cough
Urinary incontinence

40-49:

Erythema
Fatigue
Peripheral swelling
Rash
Urticaria
Amnesia
Apraxia
Confusional state
Depression
Lethargy

50-59:

Akathisia
Drug withdrawal syndrome
Insomnia
Multiple sclerosis
Osteomyelitis
Restless legs syndrome
Skin burning sensation
Suicidal ideation

60+:

Depression
Aphasia
Neoplasm malignant
Vision blurred
Amnesia
Balance disorder
Cerebral atrophy
Gait disturbance
Memory impairment
Muscular weakness

Common conditions people have *:

Insomnia (sleeplessness): 11 people, 25.58%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 13.95%
Pain: 6 people, 13.95%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 13.95%
Cystic Fibrosis (disease of the secretary glands): 5 people, 11.63%
High Blood Pressure: 5 people, 11.63%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 9.30%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 9.30%
Depression: 4 people, 9.30%
Back Disorder: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Lamictal and Krill oil?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Lamictal (77,484 reports)
Krill oil (4,231 reports)